Document is current
Any future updates will be listed below
-
Authors
Peterson, Tess E.
Hahn, Virginia S. https://orcid.org/0000-0002-0578-2668
Moaddel, Ruin https://orcid.org/0000-0002-6812-0127
Zhu, Min
Haberlen, Sabina A.
Palella, Frank J.
Plankey, Michael
Bader, Joel S. https://orcid.org/0000-0002-6020-4625
Lima, Joao A. C. https://orcid.org/0000-0001-8756-6995
Gerszten, Robert E. https://orcid.org/0000-0002-6767-7687
Rotter, Jerome I. https://orcid.org/0000-0001-7191-1723
Rich, Stephen S. https://orcid.org/0000-0003-3872-7793
Heckbert, Susan R. https://orcid.org/0000-0002-7100-512X
Kirk, Gregory D. https://orcid.org/0000-0002-7829-1405
Piggott, Damani A.
Ferrucci, Luigi https://orcid.org/0000-0002-6273-1613
Margolick, Joseph B.
Brown, Todd T.
Wu, Katherine C. https://orcid.org/0000-0003-4958-5145
Post, Wendy S. https://orcid.org/0000-0002-8655-5204
- License Information
-
More Information
Article History
Received: 24 April 2024
Accepted: 2 January 2025
First Online: 12 January 2025
Competing interests
: T.T.B. has served as a consultant to Gilead Sciences, Merck, ViiV Healthcare, and Janssen. F.J.P. has served as a consultant and/or on the Speakers Bureau for Gilead Sciences, Merck, ViiV Healthcare, and EMD Serono. S.S.R. is a consultant to the NHLBI TOPMed Administrative Coordinating Center (Westat). J.S.B. is an advisor to Dextera Biosciences, Inc. and is a founder of and advisor to Neochromosome, Inc. and its parent company Opentrons Labworks, Inc. The remaining authors declare no competing interests.
